Latest news with #AndrewHudson

IOL News
28-05-2025
- Sport
- IOL News
Andrew Hudson warns young Proteas: 'You just know you're in a fight when facing the Aussies'
Australia have an incredible will to win, says former Proteas batter Andrew Hudson. Picture: AFP Image: Picture: AFP Playing Australia is the greatest test for any cricketer. This is according to former opening batter and national convenor of selectors Andrew Hudson, as the Proteas prepare to face the defending champions in the World Test Championship final at Lord's next month. Hudson fronted up to the Aussies in two series - both home and away - back in 1994 and believes it is not just an examination of a players' technical ability, but more mental capacity to keep the 'relentless' Baggy Greens at bay. 'You knew you were in a fight, you just knew,' Hudson exclusively told Independent Media. 'They don't let go. They just keep coming. Even if you scored 100, if you've done well, they're still there to get you and make sure you don't score a big 100. 'I mean, they played very similar to us in a sense that they fought probably better when they had their backs to the wall. 'So it was, in a way, it was good because you knew you had to be on point. You couldn't go into an Australian series, half done or underprepared. They have an incredible will to win. They just wanted to win.' Video Player is loading. Play Video Play Unmute Current Time 0:00 / Duration -:- Loaded : 0% Stream Type LIVE Seek to live, currently behind live LIVE Remaining Time - 0:00 This is a modal window. Beginning of dialog window. Escape will cancel and close the window. Text Color White Black Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Background Color Black White Red Green Blue Yellow Magenta Cyan Transparency Opaque Semi-Transparent Transparent Window Color Black White Red Green Blue Yellow Magenta Cyan Transparency Transparent Semi-Transparent Opaque Font Size 50% 75% 100% 125% 150% 175% 200% 300% 400% Text Edge Style None Raised Depressed Uniform Dropshadow Font Family Proportional Sans-Serif Monospace Sans-Serif Proportional Serif Monospace Serif Casual Script Small Caps Reset restore all settings to the default values Done Close Modal Dialog End of dialog window. Advertisement Next Stay Close ✕ Ad Loading The dark art of sledging has long been part of Australia's hard-nosed tactics, and while it has set the scene for some compelling cricket when the players have gone toe-to-toe over the years, the mythical moral line has also been crossed on a few occasions. Most notably, in the first Test at the Wanderers in 1994, when Hudson was verbally abused by the late Shane Warne after being bowled around his legs. '**** off. Go on, Hudson, **** off out of here!,' Warner was heard screaming in the send off. In his autobiography, Shane Warne: My Own Story, the leg-spinner later expressed regret over his actions, and Hudson has seemingly also forgiven him for his actions. 'I think Shane epitomised the passion. I mean, he was someone who was always at you and didn't sort of let go,' Hudson said. 'I mean, he was going to get you out however, and whether it meant chirping you, whether it meant joking with you, whether it meant bowling great deliveries, he was at you all the time and was going to get you out. 'And it was relentless, you know, it didn't end there. 'But often what happened off the field was very different to what happened on the field and they were likeable people and accommodating. And we used to move through to each other's changing rooms after the games and stuff. 'Those interactions were just very normal and very pleasant. But it changed the next day (on the field).' Former Proteas batter Andrew Hudson playing a glorious cover drive. Picture: AFP Image: AFP


Business Upturn
24-04-2025
- Health
- Business Upturn
FluidForm Bio™ Announces Advance in Bioprinted Tissue Therapies with Landmark Publication in Science Advances
WALTHAM, Mass., April 24, 2025 (GLOBE NEWSWIRE) — FluidForm Bio™, a leader in cell therapies for chronic diseases such as type 1 diabetes, today announced the publication of a groundbreaking paper in the journal Science Advances detailing the development of CHIPS (Collagen-based High-resolution Internally Perfusable Scaffolds), a fully-biologic, 3D-bioprinted tissue platform engineered for internal perfusion and organ-level function. The work, led by Dr. Adam Feinberg and colleagues at Carnegie Mellon University, demonstrates the ability to fabricate centimeter-scale tissue constructs combining cells and extracellular matrix with unprecedented precision and functional fidelity. This new CHIPS platform provides a crucial technological bridge between foundational FRESH™ 3D bioprinting capabilities and FluidForm Bio's therapeutic mission—to create vascularized tissue constructs that support the viability and function of implanted islet cells. 'CHIPS represent the next generation of tissue scaffolding,' said Andrew Hudson, PhD, Co-Founder of FluidForm Bio and co-author of the paper. 'They enable not just structure, but function—supporting dynamic perfusion, vascularization, and even glucose-stimulated insulin secretion in engineered tissue constructs. This is the kind of platform our therapeutic programs require.' By combining native extracellular matrix components such as collagen and fibrin with vascular and endocrine cells—including insulin-secreting MIN6 beta-like cells—the study achieves a first: a fully-biologic, perfusable pancreatic-like tissue that responds to glucose and secretes insulin. Under perfusion, these constructs exhibited significant cell migration, vascular network formation, and insulin output, with a stimulation index beyond what is achieved with traditional biofabrication approaches. 'These results validate FRESH as the enabling technology not only for research but for our ongoing clinical translation,' said Adam Feinberg, PhD, who is also Co-Founder and Chief Technology Officer of FluidForm Bio. 'The constructs described in this paper are essentially blueprints for what we're building at FluidForm—fully cellularized, vascularized tissues for subcutaneous implantation and therapeutic function.' The CHIPS paper adds momentum to FluidForm Bio's islet cell replacement therapy program, which leverages FRESH printing to create implantable tissue scaffolds that maintain islet health, support vascularization, and promote long-term glycemic control without the need for systemic immunosuppression. The company has demonstrated sustained normoglycemia in preclinical models for over five months using this approach. The publication coincides with FluidForm Bio's live equity crowdfunding campaign on StartEngine, which invites supporters to participate in advancing the future of regenerative medicine. The paper can be found online here: About FluidForm Bio™ FluidForm Bio™ is a biotechnology company developing next-generation cell therapies for chronic diseases leveraging its proprietary FRESH™ 3D bioprinting technology platform. Using FRESH, FluidForm creates functional tissue with the same materials found in the human body, eliminating chemistries and materials known to trigger negative immune response. FRESH is a powerful vascularization platform, allowing the building of densely cellular vascularized tissue that maintains viability upon implant. The company's lead program is an islet cell therapy for type 1 diabetes in which insulin-producing beta cells are arranged in a tissue scaffold ready for subcutaneous implantation. This method is less invasive and less toxic when compared to other delivery sites, offering retrievability and reducing surgical risks and recovery time for patients. This novel approach to islet cell replacement therapy presents a transformative advancement in diabetes treatment. With superior fabrication techniques, enhanced vascularization, a robust immune modulation platform, and a convenient subcutaneous implant, this method addresses many limitations of current technologies. These improvements offer the potential for a more effective, durable, and patient-friendly therapy, offering new hope for individuals with diabetes. Founded in 2018, FluidForm is headquartered in Waltham, MA. To learn more, please visit: or connect on Twitter and LinkedIn. Contact:Corey Davis, Advisors+1 212 915 2577 [email protected]


BBC News
27-01-2025
- Business
- BBC News
Zip World: Adventure company sold in £100 million deal
Welsh adventure company Zip World has been sold in a deal that values the business at more than £100 Llanberis-based firm was established by Sean Taylor, who retains a minority stake alongside new owners Dolphin World has eight sites across Wales and England, including the world's fastest zip line - Velocity - at Penrhyn Quarry in executive Andrew Hudson said the deal would "kickstart" plans to expand the company. In February, it will open Zip World London at the Queen Elizabeth Olympic Park, and later this year it will open a new site in Elterwater, is also planning to upgrade existing sites and open more Zip World attractions across the UK. New investors Dolphin Capital already own Snowcentres Ltd, which operate indoor snow sports World CEO Andrew Hudson said: "This is just the beginning of what we hope will be a big year."Investment is key for us, not only in our new sites but also in adding value to our existing locations."We're thrilled to be opening in London and expanding our offering to communities across the UK, but north Wales remains at the heart of our company - it's where it all started and it's why we are continuing to reinvest in more adventures for the area."